Ro Offers Eli Lilly's Foundayo, the Newest GLP-1 Innovation Foundayo gives patients a new once daily pill option and expands Ros comprehensive weight loss formulary April 9, 2026 Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly Companys newest oral GLP-1 innovation on the Ro platform, adding to Ros already comprehensive formulary of FDA-approved GLP-1s
Over-the-counter products to help manage side effects Side effects remain one of the leading reasons patients discontinue GLP1 therapy
Hydrogenated Polyisobutene, Helianthus Annuus (Sunflower) SeedOil, Diisostearyl Malate, Euphorbia Cerifera (Candelilla) Wax, Simmondsia Chinensis (Jojoba) SeedOil, Octyldodecanol, Butyrospermum Parkii (Shea) Butter, Dibutyl Lauroyl Glutamide, Dibutyl Ethylhexanoyl Glutamide, Aloe Barbadensis Extract, Calophyllum Inophyllum SeedOil, Chamomilla Recutita (Matricaria) FlowerOil, Citrus Paradisi (Grapefruit) SeedOil, Argania Spinosa KernelOil, Persea Gratissima (Avocado)Oil, Daucus Carota Sativa (Carrot) SeedOil, Tocopheryl Acetate, Tetrahexyldecyl Ascorbate, Ethylhexyl Palmitate, Sorbitan Isostearate, Tribehenin, Palmitoyl Tripeptide-1
In some patients, results are seen at 4 weeks, occasionally faster
HKTV mall and the merchant do not accept responsibility for any claim, loss or damage, howsoever caused (including through omission or negligence), which you may directly or indirectly suffer in connection with the purchase of any products, services or vouchers through HKTV mall, nor do we accept any responsibility for any such claim, loss or damage arising out of your use of or reliance on information contained on or accessed through HKTV mall
By week two, new pink skin was filling in where the wound had been
